Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe symbols : Avdl save search
Avadel Pharmaceuticals Announces Publication of Real-World Data Highlighting the Risk of Accidental Dosing Errors with Immediate-Release Twice-Nightly Oxybates
Published: 2023-01-24 (Crawled : 14:00) - biospace.com/
AVDL | $17.98 -0.61% -0.61% 1.6M
|
Health Technology
|
| O: -0.57%
H: 6.76%
C: 5.47%
risk pharmaceuticals publication
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-01-10 (Crawled : 22:00) - biospace.com/
AVDL | $17.98 -0.61% -0.61% 1.6M
|
Health Technology
|
| O: -1.14%
H: 3.04%
C: 2.46%
awards nasdaq grant
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Published: 2022-11-10 (Crawled : 18:00) - biospace.com/
AVDL | $17.98 -0.61% -0.61% 1.6M
|
Health Technology
|
| O: 4.19%
H: 7.87%
C: 3.85%
pharmaceuticals conference
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results
Published: 2022-11-09 (Crawled : 13:00) - biospace.com/
AVDL | $17.98 -0.61% -0.61% 1.6M
|
Health Technology
|
| O: -2.57%
H: 6.44%
C: -5.45%
pharmaceuticals financial update results
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 9
Published: 2022-11-02 (Crawled : 23:00) - biospace.com/
AVDL | $17.98 -0.61% -0.61% 1.6M
|
Health Technology
|
| O: 1.44%
H: 3.13%
C: -3.98%
pharmaceuticals report financial update results
Avadel Pharmaceuticals to Present at the Ladenburg Thalmann Healthcare Conference
Published: 2022-09-22 (Crawled : 14:00) - biospace.com/
AVDL | $17.98 -0.61% -0.61% 1.6M
|
Health Technology
|
| O: -0.78%
H: 0.59%
C: -1.18%
pharmaceuticals conference
Avadel Pharmaceuticals Announces Interim Data from the Open-Label RESTORE Study at the 2022 American Academy of Neurology Annual Meeting
Published: 2022-04-25 (Crawled : 14:00) - biospace.com/
AVDL | $17.98 -0.61% -0.61% 1.6M
|
Health Technology
|
| O: -2.89%
H: 0.0%
C: 0.0%
Avadel Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference
Published: 2022-03-10 (Crawled : 22:00) - biospace.com/
AVDL | $17.98 -0.61% -0.61% 1.6M
|
Health Technology
|
| O: -2.02%
H: 0.0%
C: 0.0%
health als thc conference
Avadel Recognizes World Narcolepsy Day and Announces New Data Presentations from Pivotal Phase 3 REST-ON Trial of FT218 at Upcoming Conference
Published: 2021-09-20 (Crawled : 14:00) - biospace.com/
AVDL | $17.98 -0.61% -0.61% 1.6M
|
Health Technology
|
| O: -1.76%
H: 2.43%
C: 1.02%
presentation narcolepsy phase 3 ft218 trial conference
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2021 Financial Results on May 10th
Published: 2021-04-29 (Crawled : 13:15) - biospace.com/
AVDL | $17.98 -0.61% -0.61% 1.6M
|
Health Technology
|
| O: -0.13%
H: 0.63%
C: -1.38%
financial results results
Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for FT218 in Adults with Narcolepsy for the Treatment of Excessive Daytime Sleepiness and CataplexyFT218 assigned PDUFA target action date of October 15, 2021
Published: 2021-03-01 (Crawled : 21:00) - biospace.com/
AVDL | $17.98 -0.61% -0.61% 1.6M
|
Health Technology
|
| O: 0.75%
H: 4.57%
C: 2.22%
new drug treatment fda fda acceptance drug ft218 pdufa narcolepsy
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.